KPV (10mg Vial) Dosage Protocol
Anti-inflammatory tripeptide (alpha-MSH fragment) — research/educational dosing reference.
Mix & measure KPV · 10 mg
Pre-filled with this protocol’s recommended BAC water and documented starting dose — edit any field to run your own numbers.
Reconstitution math only — not dosing advice. U-100 syringe: 100 units = 1 mL. Full reconstitution guide → · Advanced calculator →
Quickstart Highlights
KPV is a tripeptide (Lysine–Proline–Valine), the C-terminal fragment of the hormone alpha-MSH, studied as an anti-inflammatory agent that appears to act inside the cell to dampen pro-inflammatory signaling such as the NF-κB pathway[1][2]. This educational page outlines a once-daily subcutaneous approach with a dilution chosen so doses land on easy-to-read insulin-syringe marks. It is an unapproved investigational research chemical, not a medicine; the evidence is preclinical (cell and animal) with no established human efficacy — presented for research and educational use only.
Add 3.0 mL bacteriostatic water to one 10 mg vial → ~3.33 mg/mL (3,333 mcg/mL), the largest practical dilution for accurate dosing.
200–500 mcg once daily, titrated upward gradually across an 8–12 week course (extendable to 16 weeks).
At ~3.33 mg/mL, 1 unit ≈ 33.3 mcg; 200 mcg = 6 units and 500 mcg = 15 units on a U-100 syringe.
Lyophilized: store at −20 °C (−4 °F); once reconstituted, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the solution.
Important: Start with the Prep & Injection Guide — it covers the preparation and safety basics every protocol on this site assumes.
Dosing & Reconstitution Guide
A single practical dilution with accurate once-daily dosing, step by step
Standard / Gradual Approach (3 mL = ~3.33 mg/mL)
Reconstitute: Add 3.0 mL bacteriostatic water to one 10 mg vial → final concentration ~3.33 mg/mL (3,333 mcg/mL).
Typical daily range: 200–500 mcg once daily, raised gradually over an 8–12 week course.
Easy measuring: At ~3.33 mg/mL, 1 unit ≈ 33.3 mcg on a U-100 syringe. Each dose lands on a whole unit mark (6–15 units) for reliable measuring accuracy.
Storage: Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the mixed solution.
Frequency: one subcutaneous injection each day, titrating up as tolerated. The schedule begins at 200 mcg and steps up by roughly 100 mcg each week to a 400–500 mcg maintenance range[3][4]. These figures are an educational reference only, not approved human dosing.
Reconstitution Steps
Draw 3.0 mL of bacteriostatic water into a sterile syringe.
Release it slowly down the vial’s inner wall to limit foaming.
Swirl or roll gently until fully dissolved — don’t shake.
Label with the date and concentration, then refrigerate at 2–8 °C (35.6–46.4 °F), shielded from light.
The 3.0 mL dilution lands every dose on a whole unit mark (6–15 units), where U-100 syringe readings are easy and precise. Avoid freezing the reconstituted solution, since freeze–thaw can denature the peptide.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
Quantities below assume an 8–16 week course of once-daily injections with gradual titration.
A 10 mg vial covers several weeks at 200–500 mcg/day, so a full course needs only a few vials.
- 8 weeks: ~3 vials
- 12 weeks: ~4 vials
- 16 weeks: ~6 vials
- Per injection: 1 syringe
- 8 weeks (once daily): ~56 syringes
- 16 weeks (once daily): ~112 syringes
Use ~3.0 mL per 10 mg vial for reconstitution.
- 8 weeks (3 vials): ~9 mL → 1 bottle
- 16 weeks (6 vials): ~18 mL → 2 bottles
One for the vial stopper + one for the injection site each day.
- Per injection: 2 swabs
- 8 weeks (once daily): ~112 swabs → 1–2 boxes
Protocol Overview
A concise summary of the once-daily regimen, drawn from commonly cited reference protocols.
- ▪Goal: Explore the anti-inflammatory activity attributed to this alpha-MSH fragment — effects reported in cell and animal models only, not established in humans[5][6].
- ▪Schedule: Daily subcutaneous injections for 8–12 weeks, optionally extended to ~16 weeks for longer research goals.
- ▪Dose Range: 200–500 mcg per day with gradual weekly titration.
- ▪Reconstitution: 3.0 mL bacteriostatic water per 10 mg vial gives ~3.33 mg/mL for accurate unit measurements.
- ▪Storage: Keep the dry vial frozen at −20 °C (−4 °F); once mixed, refrigerate at 2–8 °C and do not freeze the solution.
Dosing Protocol
A suggested daily titration approach based on common reference doses.
- ▪Start: Begin at 200 mcg once daily to gauge tolerability.
- ▪Titrate: Increase by roughly 100 mcg each week as tolerated.
- ▪Target: Reach a 400–500 mcg daily maintenance range by weeks 4–8.
- ▪Cycle Length: Typically 8–12 weeks; some references extend to ~16 weeks.
- ▪Timing: Inject at a consistent time each day and rotate injection sites systematically.
Storage Instructions
Correct storage is what preserves the peptide’s stability and activity.
- ▪Lyophilized: Hold the dry vial at −20 °C (−4 °F) in dry, dark conditions and limit moisture exposure[7].
- ▪Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F) and use within about 28 days; do not freeze the mixed solution, as freezing can denature peptides[8].
- ▪Handling: Let frozen vials warm to room temperature before opening so condensation won’t form, and keep the solution clear of heat and direct light.
- ▪Freeze–thaw: Avoid repeated freeze–thaw cycles of the reconstituted solution.
Important Notes
Practical points that keep daily administration safe and consistent.
- ▪Sterile technique: Use a fresh sterile U-100 insulin syringe each time and drop it straight into a puncture-proof sharps container afterward.
- ▪Site rotation: Move between abdomen, thighs and upper arms to reduce local irritation and lipohypertrophy[9].
- ▪Slow injection: Push the plunger slowly and pause a few seconds before withdrawing the needle to prevent backflow.
- ▪Recordkeeping: Log the daily dose, injection site and any observations to keep the protocol consistent.
- ▪Regulatory note: KPV is an investigational research chemical and is not approved by any major regulator for human use; the evidence base is preclinical only[10].
How This Works
KPV is a tripeptide made of Lysine-Proline-Valine — the C-terminal fragment (residues 11–13) of the hormone alpha-melanocyte-stimulating hormone (α-MSH)[1][2]. It retains much of the parent hormone’s anti-inflammatory character while lacking its pigment-related (melanotropic) effects.
Its proposed mechanism is intracellular: rather than acting only at a surface receptor, KPV is thought to enter the cell and dampen pro-inflammatory signaling — including the NF-κB pathway — which in turn lowers the output of inflammatory mediators[5][6]. Much of the laboratory interest has centred on gut inflammation (models of IBD and colitis) and skin inflammation.
In preclinical work, peptide-transporter uptake (e.g. PepT1 in intestinal cells) has been described as one route by which the tripeptide reaches its intracellular targets[11]. These findings come from cell and animal studies, and the magnitude and relevance of any effect in humans remains unknown.
Important caveat: KPV is not approved by any major regulator, and there are no established human efficacy results. The evidence is entirely preclinical; reports of anti-inflammatory benefit should be read as research hypotheses, not demonstrated outcomes[13].
KPV is not an approved medicine. It is an investigational research chemical presented here for research and educational purposes only.
Lifestyle Factors
Habits that may support general wellbeing alongside the protocol.
- ▪Nutrition: Favour a balanced, whole-food diet; anti-inflammatory eating patterns may complement the protocol.
- ▪Activity & rest: Pair appropriate movement with real recovery time and avoid excess physical stress.
- ▪Sleep: Aim for 7–9 hours, since sleep influences immune and inflammatory balance.
- ▪Stress: Manage stress with evidence-based practices, since it influences inflammation and overall wellbeing.
Potential Benefits & Side Effects
What preclinical (cell and animal) literature describes; there is no established human evidence, and any effects are unproven.
Potential Benefits
- ▪Gut inflammation (preclinical): In animal models of colitis/IBD, the peptide has been reported to reduce markers of intestinal inflammation[5][6].
- ▪Inflammatory signaling (preclinical): Cell studies describe dampened pro-inflammatory signaling (e.g. NF-κB) and lower cytokine output[11].
- ▪Skin inflammation (preclinical): Topical and dermal models have explored anti-inflammatory effects on irritated skin.
- ▪Note on humans: None of these effects are established in humans — the evidence is preclinical and no controlled human efficacy trials support these uses[13].
Common Side Effects
- ▪Injection-site reactions: Mild redness, tenderness or soreness can occur; rotating sites helps.
- ▪Unknown long-term profile: Human safety data is limited, so caution and monitoring are advised.
- ▪Unapproved status: KPV is not approved by any major regulator and is intended for research use only.
Injection Technique
General subcutaneous technique, following established clinical best-practice guidance[14][15].
Pre-Injection Preparation
- ▪Wash your hands well with soap and water.
- ▪Wipe the vial stopper with an alcohol swab and let it air-dry.
- ▪Choose a site (abdomen, thigh, or upper arm) and clean it with a fresh alcohol swab, letting it dry fully[15].
- ▪Draw the intended dose, then check for air bubbles and push any out.
Injection Procedure
- ▪Pinch a skinfold at the chosen site between thumb and forefinger.
- ▪Insert the needle into the pinch at a 45–90-degree angle (use 45 degrees if the fat layer is thin)[14].
- ▪Skip aspiration for subcutaneous shots — it isn’t needed[14].
- ▪Press the plunger slowly and steadily until it’s fully down.
- ▪Wait 5–10 seconds, then pull the needle straight out to prevent leakage.
Post-Injection Care
- ▪Drop the used syringe straight into a puncture-proof sharps container — never recap a needle.
- ▪Return the reconstituted vial to the fridge right away.
- ▪Rotate the injection site each day to prevent irritation and lipohypertrophy[9].
- ▪Watch the site for excess redness, swelling, or signs of infection.
Recommended Source
For high-purity research peptides, we point researchers to Prime Lab Peptides. Note that a KPV 10 mg vial is not currently a listed product, so the link goes to the supplier’s main site.
Why Prime Lab Peptides?
- ▪Top-rated on Trustpilot: Independently reviewed as the highest-rated peptide lab on Trustpilot — making it the best current source in the USA.
- ▪Third-party tested: Every batch ships with a Certificate of Analysis (COA) confirming purity and composition.
- ▪Consistent quality: ISO-aligned manufacturing and handling keep product integrity reliable batch to batch.
- ▪Cold-chain integrity: Temperature-controlled shipping and storage across the whole fulfilment chain.
- ▪Research-grade purity: Fit for educational and research use that demands high-quality peptides.
Note: Product availability and specifications subject to change. Verify current product details on supplier website.
References
- 1
FASEB JournalKPV identified as the C-terminal tripeptide of alpha-MSH retaining anti-inflammatory activity.
- 2
Journal of Chromatography A (PubMed)Studies of the alpha-MSH C-terminal sequence and its anti-inflammatory tripeptide KPV.
- 3
PubMed (NCBI)Review of KPV anti-inflammatory activity in preclinical models (dose and exposure context).
- 4
Racing Medication & Testing ConsortiumPreclinical dosing context for small anti-inflammatory peptides such as KPV.
- 5
Journal of Investigative Dermatology (PubMed)KPV reduces intestinal inflammation in animal models of colitis/IBD.
- 6
FASEB Journal (PubMed)KPV and intestinal anti-inflammatory effects in experimental colitis models.
- 7
Peptide Storage GuideBest practices for storing lyophilized peptides (temperature, humidity and light protection).
- 8
Bacteriostatic Water GuidanceBacteriostatic water for injection: multi-dose vial stability and handling.
- 9
NCBI BookshelfBest practices for subcutaneous injection: aseptic technique and site rotation.
- 10
FDA — Unapproved DrugsRegulatory status: KPV is an unapproved investigational research chemical, not approved for human use.
- 11
Journal of Investigative DermatologyKPV transport (e.g. via PepT1) and intracellular anti-inflammatory signaling, including NF-kB modulation.
- 12
Journal of Chromatography B (PubMed)Mechanistic studies of KPV effects on pro-inflammatory cytokine signaling in cell models.
- 13
ClinicalTrials.govClinical-trial registry: no completed human efficacy trials establish KPV for any indication.
- 14
Centers for Disease Control and Prevention (CDC)Subcutaneous injection technique: angle, site and no-aspiration guidance.
- 15
Subcutaneous Injection Technique (Patient Education)How to administer a subcutaneous injection: clinical technique guidelines.
- 16
Prime Lab PeptidesPrime Lab Peptides supplier site (KPV 10 mg is not a listed product; link goes to the main site).
How to reconstitute KPV
- 1Wipe the vial stopper and your bacteriostatic-water vial with an alcohol swab.
- 2Draw your chosen amount of bacteriostatic water and inject it slowly down the inner wall of the KPV vial.
- 3Let it rest, then gently swirl until fully dissolved — do not shake.
- 4Refrigerate the reconstituted vial and draw each dose with a U-100 insulin syringe.
KPV — frequently asked questions
How do I reconstitute a 10 mg vial of KPV?
Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units.
How much bacteriostatic water should I add to KPV?
There is no single correct amount — more water simply spreads the same 10 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units.
What do the "units" on an insulin syringe mean?
On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand.
How should I store KPV after mixing?
Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product.
How many doses does a 10 mg vial of KPV provide?
Divide the vial strength of 10 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose.
Is KPV approved for human use?
No. KPV is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.
New protocols & dosing updates
Reconstitution charts, new peptide protocols and safety updates — straight to your inbox. No spam, unsubscribe anytime.